Letter on “Sharing trial results directly with trial participants and other stakeholders after the SARS-CoV-2 pandemic hit the UK – experience from the ActWELL trial”

Trials

Amy Hickman¹  Annie S. Anderson²  E. Jane Macaskill³  Hanne Bruhn⁴  Shaun Treweek⁴ 

[1] Breast Cancer Now;Centre for Research into Cancer Prevention and Screening, University of Dundee;Department of Breast Surgery, Level 6, Ninewells Hospital and Medical School;Health Services Research Unit, University of Aberdeen;

关键词: Randomised trials;    Research transparency;    Result dissemination;    Trial conduct;    Online events;    COVID-19;   

DOI  :  10.1186/s13063-021-05340-3

来源: DOAJ

【 摘 要 】

Abstract After the SARS-CoV-2 pandemic took hold in the UK, the ActWELL trial team’s plans to present the trial results to participants and other stakeholders had to change. Instead of face-face events, three online events were planned and hosted successfully. In this article, we describe the choices made in planning and organisation of the online events including things we would do differently if we were to do it again. We think that online events are a useful platform when informing participants and other stakeholders of the results of your trial, even beyond the SARS-CoV-2 pandemic, and we hope this article can help other trial teams to plan their own online events.

【 授权许可】

Unknown